Krystal Biotech, Inc. KRYS Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s shares (diluted)?
- Krystal Biotech, Inc. (KRYS) reported shares (diluted) of 30.5M in Q1 2026.
- How has Krystal Biotech, Inc.'s shares (diluted) changed year-over-year?
- Krystal Biotech, Inc.'s shares (diluted) increased by 2.1% year-over-year, from 29.9M to 30.5M.
- What is the long-term trend for Krystal Biotech, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Krystal Biotech, Inc.'s shares (diluted) has grown at a 8.0% compound annual growth rate (CAGR), from 87.9M to 119.4M.
- What does shares (diluted) mean?
- The average number of shares that would exist if all potential share-based instruments were converted.
- How do you interpret shares (diluted)?
- A higher number relative to basic shares indicates a larger potential for dilution, which can impact future earnings per share.
- How does shares (diluted) compare across companies?
- Standard metric for assessing potential dilution; comparable across companies with similar equity incentive plans.